Treatment of postmenopausal osteoporosis.
D000368:Aged; D045930:Anabolic Agents / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D005082:Physical Exertion; D012969:Sodium Fluoride / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use
D045930:Anabolic Agents; D000728:Androgens; D004164:Diphosphonates; D004967:Estrogens; D014807:Vitamin D; D012969:Sodium Fluoride; D002116:Calcitonin; D002118:Calcium